WEIL:\99660008\5\43717.0003 April [ ], 2024 NAME ADDRESS Via Email: XXX@ebsi.com RE: Amendment to Key Employee Retention Program Dear [ ]: In recognition of your continuing key role at Emergent BioSolutions Inc. (the "Company"), you and the Company...Emergent BioSolutions Inc. • April 26th, 2024 • Pharmaceutical preparations • Maryland
Company FiledApril 26th, 2024 Industry Jurisdiction